TABLE 2.
SFSV | ||||||
Variable | Category | n | Seropositive proportion | Odds ratio | 95% CI | Chi-square P-value |
Location | ||||||
Alp | 94 | 0.447 | 1.000 | |||
Mallorca | 16 | 0.500 | 1.238 | 0.428–3.577 | 0.693a | |
Year | ||||||
2018 | 19 | 0.895 | 1.000 | |||
2019 | 54 | 0.500 | 0.118 | 0.024–0.559 | 0.007 | |
2021 | 37 | 0.162 | 0.023 | 0.004–0.125 | <0.001 | |
Age class | ||||||
Juveniles | 29 | 0.345 | 1.000 | |||
Adults | 79 | 0.494 | 1.852 | 0.766–4.483 | 0.171 | |
TOSV | ||||||
Variable | Category | n | Seropositive proportion | Odds ratio | 95% CI | Chi-square P-value |
Location | ||||||
Alp | 90 | 0.411 | 1.000 | |||
Mallorca | 16 | 0.500 | 1.432 | 0.493–4.160 | 0.509a | |
Year | ||||||
2018 | 19 | 0.368 | 1.000 | |||
2019 | 51 | 0.569 | 2.300 | 0.764–6.684 | 0.141 | |
2021 | 36 | 0.250 | 0.571 | 0.172–1.896 | 0.360b | |
Age class | ||||||
Juveniles | 28 | 0.500 | 1.000 | |||
Adults | 76 | 0.395 | 0.652 | 0.273–1.560 | 0.337 |
a: comparison between location (same year 2019) p-value = 0.504.
b: comparison between years (2019–2021) p-value = 0.011.